TrialTherapeutic advances in respiratory disease2016

A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma.

Andrzej Emeryk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.